Sylvia Rofael

Dr. Sylvia Rofael


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
JTJuliano Timm
Juliano Timm
ABAnna Bateson
Anna Bateson
PSPriya Solanki
Priya Solanki
APAna Paleckyte
Ana Paleckyte
AWAdam A. Witney
Adam A. Witney
ESEugene Sun
Eugene Sun
Bedaquiline (B), pretomanid (Pa) and linezolid (L) are key components of new regimens for treating rifampicin-resistant tuberculosis (TB). However, there is limited information on the global prevalence of resistance to these drugs and the impact of resistance on treatment outcomes. Mycobacterium tuberculosis (MTB) phenotypic drug susceptibility and whole-genome sequence (WGS) data, as well as patient profiles from 4 pretomanid-containing trials–STAND, Nix-TB, ZeNix and SimpliciTB–were used to investigate the rates of baseline resistance (BR) and acquired resistance (AR) to BPaL drugs, as well as their genetic basis, risk factors and impact on treatment outcomes. Data from >1,000 TB patients enrolled from 2015 to 2020 in 12 countries was assessed. We identified 2 (0.3%) participants with linezolid BR. Pretomanid BR was also rare, with similar rates across TB drug resistance types (0–2.1%). In contrast, bedaquiline BR was more prevalent among participants with highly resistant TB or longer prior treatment histories than those with newly diagnosed disease (5.2–6.3% vs. 0–0.3%). Bedaquiline BR was a risk factor for bacteriological failure or relapse in Nix-TB/ZeNix; 3/12 (25%, 95% CI 5–57%) participants with vs. 6/185 (3.2%, 1.2–6.9%) without bedaquiline BR. Across trials, we observed no linezolid AR, and only 3 cases of bedaquiline AR, including 2 participants with poor adherence. Overall, pretomanid AR was also rare, except in ZeNix patients with bedaquiline BR. WGS analyses revealed novel mutations in canonical resistant genes and, in 7 MTB isolates, the genetic determinants could not be identified. The overall low rates of BR to linezolid and pretomanid, and to a lesser extent to bedaquiline, observed in the pretomanid trials are in support of the worldwide implementation of BPaL-based regimens. Similarly, the overall low AR rates observed suggest BPaL drugs are better protected in the regimens trialed here than in other regimens combining bedaquiline with more, but less effective drugs.

1 July 2020 in eClinicalMedicine
Verified
Journal Article
Open access
SRSylvia Rofael
Sylvia Rofael
JBJames Brown
James Brown
EPElisha Pickett
Elisha Pickett
MJMargaret Johnson
Margaret Johnson
JHJohn R. Hurst
John R. Hurst
TMTimothy McHugh
Timothy McHugh
Long-term antiretroviral therapy (ART) enables people living with HIV (PLW-HIV) to be healthier and live longer; though they remain at greater risk of pneumonia and chronic lung disease than the general population. Lung microbial dysbiosis has been shown to contribute to respiratory disease. 16S-rRNA gene sequencing on the Miseq-platform and qPCR for typical respiratory pathogens were performed on sputum samples collected from 64 PLW-HIV (median blood CD4 count 676 cells/μL) and 38 HIV-negative participants. Richness and α-diversity as well as the relative-abundance (RA) of the major taxa (RA>1%) were similar between both groups. In unweighted-Unifrac ß-diversity, the samples from PLW-HIV showed greater diversity, in contrast to the HIV negative samples which clustered together. Gut bacterial taxa such as Bilophila and members of Enterobacteriaceae as well as pathogenic respiratory taxa (Staphylococcus, Pseudomonas and Klebsiella) were significantly more frequent in PLW-HIV and almost absent in the HIV-negative group. Carriage of these taxa was correlated with the length of time between HIV diagnosis and initiation of ART (Spearman-rho=0·279, p=0·028). Although the core airway microbiome was indistinguishable between PLW-HIV on effective ART and HIV-negative participants, PLW-HIV's respiratory microbiome was enriched with potential respiratory pathogens and gut bacteria. The observed differences in PLW-HIV may be due to HIV infection altering the local lung microenvironment to be more permissive to harbour pathogenic bacteria that could contribute to respiratory comorbidities. Prompt start of ART for PLW-HIV may reduce this risk.

1 September 2025 in Microbial Genomics
Verified
Journal Article
Open access
LELinzy Elton
Linzy Elton
AMAlonso Dupuy Mateos
Alonso Dupuy Mateos
SFSian-Marie Frosini
Sian-Marie Frosini
RJRosanne E. Jepson
Rosanne E. Jepson
SRSylvia Rofael
Sylvia Rofael
EWEmmanuel Q. Wey
Emmanuel Q. Wey
There are currently no standardized guidelines for genomic surveillance of One Health antimicrobial resistance (AMR). This project aimed to utilize metagenomics to identify AMR genes present in a companion animal hospital and compare these with phenotypic results from bacterial isolates from clinical specimens from the same veterinary hospital. Samples were collected from sites within a primary care companion animal veterinary hospital in London, UK. Metagenomic DNA was sequenced using Oxford Nanopore Technologies MinION. The sequencing data were analysed for AMR genes, plasmids and clinically relevant pathogen species. These data were compared to phenotypic speciation and antibiotic susceptibility tests of bacterial isolates from patients. The most common resistance genes identified were aph (n=101 times genes were detected across 48 metagenomic samples), sul (84), bla CARB (63), tet (58) and bla TEM (46). In clinical isolates, a high proportion of isolates were phenotypically resistant to β-lactams. Rooms with the greatest mean number of resistance genes identified per swab site were the medical preparation room, dog ward and surgical preparation room. Twenty-four and four plasmids typically associated with Gram-positive and Enterobacteriaceae, respectively, were identified. Sequencing reads matched with 14 out of 22 (64%) of the phenotypically isolated bacterial species. Metagenomics identified AMR genes, plasmids and species of relevance to human and animal medicine. Communal animal-handling areas harboured more AMR genes than areas animals did not frequent. When considering infection prevention and control measures, adherence to, and frequency of, cleaning schedules, alongside potentially more comprehensive disinfection of animal-handling areas, may reduce the number of potentially harmful bacteria present.

10 February 2025 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
LELinzy Elton
Linzy Elton
AAAlp Aydin
Alp Aydin
NSNeil Stoker
Neil Stoker
SRSylvia Rofael
Sylvia Rofael
LWLetícia Muraro Wildner
Letícia Muraro Wildner
TMTimothy D. McHugh
Timothy D. McHugh
Delays in accurate diagnosis of drug resistant tuberculosis (DR-TB) can hinder treatment. Whole genome sequencing (WGS) provides more information than standard molecular and phenotypic testing, but commonly used platforms are expensive to implement, and data interpretation requires significant expertise. We aimed to optimise a TB WGS diagnostic pipeline balancing user-friendliness, cost-effectiveness and time to results, whilst ensuring accuracy. Growth conditions, DNA extraction protocols and Oxford Nanopore Technologies (ONT) library preparation kits were compared. ONT was compared with Illumina protocols. Software for basecalling and analysis were evaluated to find the most accurate resistance SNP and lineage predictor. Optimally, a spin-column CTAB DNA extraction method was combined with the RBK110.96 library preparation kit, high accuracy (HAC) basecalling and data analysis using TB-Profiler. Compared with Illumina, the pipeline was concordant for 16/17 (94%) isolates (lineage) and for 17/17 (100%) isolates (resistance SNPs). Our pipeline was 71% (12/17) concordant with phenotypic drug susceptibility test (DST) results. Time-to-diagnosis was around four weeks. This optimised TB sequencing pipeline requires less time and expertise to run and analyse than Illumina, takes less time than phenotypic DSTs and the results are comparable with Illumina. The cost per sample is comparable with other methods. These features make it an important tool for incorporating into routine DR-TB diagnostic pipelines and larger scale drug resistance surveillance in all settings.

14 February 2025 in bioRxiv
Verified
Preprint
Open access
LELinzy Elton
Linzy Elton
AMAlonso Dupuy Mateos
Alonso Dupuy Mateos
SFSian-Marie Frosini
Sian-Marie Frosini
RJRosanne E. Jepson
Rosanne E. Jepson
SRSylvia Rofael
Sylvia Rofael
EWEmmanuel Q Wey
Emmanuel Q Wey
Introduction: There are currently no standardised guidelines for genomic surveillance of One Health (OH) antimicrobial resistance (AMR). This project aimed to utilise metagenomics to identify AMR genes present in a companion animal hospital and compare these with phenotypic results from bacterial isolates from clinical specimens from the same veterinary hospital. Methods: Samples were collected from sites around a primary companion animal veterinary hospital in North London. Metagenomic DNA was sequenced using Oxford Nanopore Technologies (ONT) MinION. The sequencing data were analysed for AMR genes, plasmids and clinically relevant pathogen species. These data were compared to phenotypic speciation and antibiotic susceptibility tests (ASTs) of bacteria isolates from patients. Results: The most common resistance genes identified were aph (n=101 times genes were isolated across 48 metagenomic samples), sul (84), bla CARB (63), tet (58) and bla TEM (46). In clinical isolates, a high proportion of phenotypic resistance to the β-lactams was identified. Rooms with the greatest mean number of resistance genes identified per swab site were the medical preparation room, dog ward and surgical preparation room. Twenty-four Gram-positive and four enterobacterial plasmids were identified. Sequencing reads matched with 14/22 (64%) of the phenotypically isolated bacterial species. Discussion: Metagenomics identified AMR genes, plasmids and species of relevance to human and animal medicine. Communal animal-handling areas harboured more AMR genes than areas animals did not frequent. When considering infection prevention and control (IPC) measures, adherence to, and frequency of, cleaning schedules, alongside potentially more comprehensive disinfection of animal-handling areas may reduce the number of potentially harmful bacteria present. PubMed “veterinary” or “companion” AND “AMR” or “resistan*” NOT (Review[Publication Type]) (2018-2023) “veterinary” or “companion” AND “AMR” or “resist*” AND “sequencing” or “metagenomic*” “veterinary” or “companion” AND “AMR” or “resistan*” NOT (Review[Publication Type]) (2018-2023) https://www.iscaid.org/clinical-practice

15 April 2024 in medRxiv
Verified
Preprint
Open access
PDF file
LELinzy Elton
Linzy Elton
AAAlp Aydin
Alp Aydin
NSNeil Stoker
Neil Stoker
SRSylvia Rofael
Sylvia Rofael
LWLetícia Muraro Wildner
Letícia Muraro Wildner
TMTimothy McHugh
Timothy McHugh
Background Delays in accurate diagnosis of drug resistant tuberculosis (DR-TB) can hinder treatment. Whole genome sequencing (WGS) provides more information than standard molecular and phenotypic testing, but commonly used platforms are expensive to implement, and data interpretation requires significant expertise. Aims We aimed to optimise a TB WGS diagnostic pipeline balancing user-friendliness, cost- effectiveness and time to results, whilst ensuring accuracy. Materials and methods Growth conditions, DNA extraction protocols and Oxford Nanopore Technologies (ONT) library preparation kits were compared. Software for basecalling and analysis were evaluated to find the most accurate resistance SNP and lineage predictor. Results Optimally, a spin-column CTAB DNA extraction method was combined with the RBK110.96 library preparation kit, high accuracy basecalling and data analysis using TB-Profiler. Compared with Illumina, the pipeline was concordant for 16/17 (94%) isolates (lineage) and for 17/17 (100%) isolates (resistance SNPs). Our pipeline was 71% (12/17) concordant with phenotypic drug susceptibility test (DST) results. Time-to-diagnosis was around four weeks. Conclusions This optimised TB sequencing pipeline requires less time expertise to run and analyse than Illumina, takes less time than phenotypic DSTs and the results are comparable with Illumina. The cost per sample is comparable with other methods. These features make it an important tool for incorporating into routine DR-TB diagnostic pipelines and larger scale drug resistance surveillance in all settings.